Editorial: Bioresponsive nanomaterials for drug delivery or controlled release

Yan Pan; Kezhen Qi; Jijun Fu; Wei Gao; Zhao Li; Zhiqiang Lin

doi:10.3389/fbioe.2023.1165782

Editorial: Bioresponsive nanomaterials for drug delivery or controlled release

Front Bioeng Biotechnol. 2023 Mar 20:11:1165782. doi: 10.3389/fbioe.2023.1165782. eCollection 2023.

Authors

Yan Pan¹, Kezhen Qi², Jijun Fu³, Wei Gao⁴, Zhao Li⁵, Zhiqiang Lin¹

Affiliations

¹ Department of Pharmacology, Institute of Systems Biomedicine, Beijing Key Laboratory of Tumor Systems Biology, School of Basic Medical Sciences, Peking University, Beijing, China.
² College of Pharmacy, Dali University, Dali, Yunnan, China.
³ Key Laboratory of Molecular Target and Clinical Pharmacology, School of Pharmaceutical Sciences, The First Affiliated Hospital of Guangzhou Medical University and the Fifth Affiliated Hospital of Guangzhou Medical University, Guangzhou Medical University, Guangzhou, China.
⁴ Department of Pharmaceutical Sciences, College of Pharmacy, Rogel Cancer Center, University of MI, Ann Arbor, MI, United States.
⁵ Department of Hepatobiliary Surgery, Peking University People's Hospital, Beijing, China.

No abstract available

Keywords: bioresponsive nanomaterials; controlled release; drug delivery; novel nanomedicine; targeting.

Publication types

Editorial

Grants and funding

This work was supported by grants including the Beijing Natural Science Foundation (grant L202049 to ZL) and the National Natural Science Foundation of China (grant U20A20412 to QZ).